Markets:

Overview

News

Currencies

International

Treasuries

Eagle Pharmaceuticals, Inc. - Common Stock (NQ:EGRX)

2.140 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Eagle Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >

Eagle Pharmaceuticals: Q2 Earnings Insights ↗

August 09, 2022

Eagle Pharmaceuticals (NASDAQ:EGRX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:50 AM. Here's what investors need to know about the announcement. Earnings Eagle Pharmaceuticals...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 22, 2022

During Friday's session, 61 companies made new 52-week lows.

Via Benzinga

Perrigo Stock Mystery; Big Money Loves It, Though Profits Slim ↗

July 12, 2022

Institutional investors like mutual funds can't get enough of Perrigo stock. It has an A Accumulation/Distribution Rating.

Via Investor's Business Daily

Short Volatility Alert: Eagle Pharmaceuticals, Inc. ↗

June 15, 2022

On Tuesday, shares of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) experienced volatile short activity. After the activity, the stock price went up +2.39% to $43.35. The overall sentiment for EGRX has...

Via Benzinga

Recap: Eagle Pharmaceuticals Q1 Earnings ↗

May 09, 2022

Eagle Pharmaceuticals (NASDAQ:EGRX) reported its Q1 earnings results on Monday, May 9, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Eagle Pharmaceuticals Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

May 04, 2022

Eagle Pharmaceuticals (NASDAQ:EGRX) will host a conference call at 08:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results.

Via Benzinga

Eagle Pharma Adds Hospital-Based Products With €95M Acacia Pharma Deal ↗

March 28, 2022

Eagle Pharmaceuticals Inc (NASDAQ: EGRX) has agreed to acquire Acacia Pharma Group plc

Via Benzinga

Eagle Pharma's Q4 Earnings Miss Street View On Lower Product Sales ↗

March 07, 2022

Eagle Pharmaceuticals Inc's (NASDAQ: EGRX) Q4 FY21 sales declined 15% Y/Y to $42.3 million, missing the consensus of $51.08 million. The sales declined primarily...

Via Benzinga

Eagle Pharmaceuticals: Q4 Earnings Insights ↗

March 07, 2022

Eagle Pharmaceuticals (NASDAQ:EGRX) reported its Q4 earnings results on Monday, March 7, 2022 at 06:50 AM. Here's what investors need to know about the announcement....

Via Benzinga

Earnings Scheduled For March 7, 2022 ↗

March 07, 2022

Companies Reporting Before The Bell • Niu Technologies (NASDAQ:NIU) is expected to report quarterly earnings at $0.21 per share on revenue of $144.02 million. •...

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

Eagle Pharmaceuticals's Earnings Outlook ↗

March 04, 2022

Eagle Pharmaceuticals (NASDAQ:EGRX) is set to give its latest quarterly earnings report on Monday, 2022-03-07. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO ↗

December 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Vir Biotech Says COVID-19 Antibody Treatment Effective Against Omicron...

Via Benzinga

The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More ↗

December 12, 2021

Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into risky bets amid the broader market rebound. Multiple...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates ↗

December 02, 2021

A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for...

Via Benzinga

Eagle Pharmaceuticals, inc (EGRX) Q3 2021 Earnings Call Transcript ↗

November 09, 2021

EGRX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

33 Stocks Moving In Tuesday's Mid-Day Session ↗

August 31, 2021

Gainers AC Immune SA (NASDAQ: ACIU) shares jumped 68.4% to $11.77. AC Immune and its collaborating partner Genentech, part of Roche Holdings, announced topline data from Phase 2...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug ↗

August 25, 2021

ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗

October 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...

Via Benzinga

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

Eagle Pharmaceuticals, inc (EGRX) Q2 2021 Earnings Call Transcript ↗

August 09, 2021

EGRX earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug ↗

September 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...

Via Benzinga

The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive ↗

September 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (...

Via Benzinga

Eagle Pharmaceuticals In-Licenses US Rights For Emergency Hospital Product, Q2 Earnings Beat Consensus ↗

August 09, 2021

Eagle Pharmaceuticals Inc (NASDAQ: EGRX) has entered into a licensing agreement with AOP Orphan Pharmaceuticals GmbH for the commercial rights to its product,...

Via Benzinga

Topics Earnings

Recap: Eagle Pharmaceuticals Q2 Earnings ↗

August 09, 2021

Shares of Eagle Pharmaceuticals (NASDAQ:EGRX) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were up 63.16% year over year to $0...

Via Benzinga

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗

September 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...

Via Benzinga

Eagle Pharmaceuticals: Return On Capital Employed Insights ↗

June 22, 2021

During Q1, Eagle Pharmaceuticals (NASDAQ:EGRX) brought in sales totaling $41.25 million. However, earnings decreased 138.53%, resulting in a loss of $3.77 million. In Q4, Eagle...

Via Benzinga

55 Biggest Movers From Yesterday ↗

September 01, 2021

Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Eagle Pharmaceuticals, Inc. - Common Stock (NQ:EGRX)

Headline News about Eagle Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today